Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pavmed Inc 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 USA

www.pavmed.com P: 917-813-1828

Description:

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 6,696
Enterprise Value, $K -9,954
Shares Outstanding, K 9,432
Annual Sales, $ 2,450 K
Annual Net Income, $ -64,180 K
Last Quarter Sales, $ 1,010 K
Last Quarter Net Income, $ -15,210 K
EBIT, $ -60,540 K
EBITDA, $ -57,610 K
60-Month Beta 0.66
% of Insider Shareholders 12.60%
% of Institutional Shareholders 19.93%
Float, K 8,243
% Float 87.40%
Short Volume Ratio 0.27

Growth:

1-Year Return -88.44%
3-Year Return -99.19%
5-Year Return -95.49%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -19.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.99 on 05/13/24
Next Earnings Date 08/20/24
Earnings Per Share ttm -5.56
EPS Growth vs. Prev Qtr 36.94%
EPS Growth vs. Prev Year 33.97%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/07/23

PAVM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -99.19%
Profit Margin % -2,619.59%
Debt/Equity 0.00
Price/Sales 3.13
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.18
Interest Coverage -133.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar